Theraclion Share Price OTC Markets
Stocks
TCLIF
FR0010120402
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5320 USD | +66.25% |
|
-.--% | +66.25% |
| 24/07 | Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026 | CI |
| 09/07 | Theraclion Announces Board Changes | CI |
| Market Cap | 4.46Cr 5.14Cr 4.18Cr 3.82Cr 7.21Cr 489.53Cr 7.31Cr 49Cr 19Cr 244.59Cr 19Cr 19Cr 814.09Cr | P/E 2024 |
-2.66x | P/E 2025 | -6.33x |
|---|---|---|---|---|---|
| Enterprise Value | 5.24Cr 6.04Cr 4.91Cr 4.49Cr 8.48Cr 575.73Cr 8.59Cr 57Cr 23Cr 287.65Cr 23Cr 22Cr 957.42Cr | EV / Sales 2024 |
22.5x | EV / Sales 2025 | 55.4x |
| Free-Float |
54.37% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +66.25% | ||
| 6 months | +66.25% | ||
| Current year | +66.25% |
| Current year | 0.53 | 0.53 | |
| 1 year | 0.53 | 0.53 | |
| 3 years | 0 | 0.59 | |
| 5 years | 0 | 2.28 | |
| 10 years | 0 | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Deterre
CEO | Chief Executive Officer | - | 24/05/2023 |
Julie Veisseire
DFI | Director of Finance/CFO | - | - |
Alexandra Rocher
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Renaud Saleur
BRD | Director/Board Member | - | 01/02/2018 |
Ari Kellen
BRD | Director/Board Member | - | 13/02/2019 |
Shawn Langer
BRD | Director/Board Member | - | 13/02/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +66.25% | -.--% | - | - | 5.15Cr | ||
| -0.42% | -0.31% | +28.08% | +4.21% | 21TCr | ||
| -0.57% | +1.18% | +1.70% | -22.35% | 14TCr | ||
| -0.03% | +6.28% | -20.87% | +21.31% | 13TCr | ||
| +3.91% | +8.02% | -51.73% | -2.05% | 6.92TCr | ||
| +0.08% | +2.47% | +13.30% | +11.55% | 5.13TCr | ||
| -0.36% | +5.11% | -14.27% | -19.86% | 5.04TCr | ||
| -0.39% | +1.14% | +23.90% | +10.89% | 3.99TCr | ||
| -1.00% | +4.03% | +42.46% | +36.56% | 3.93TCr | ||
| +0.17% | +7.59% | -19.99% | +20.21% | 3.23TCr | ||
| Average | +6.77% | +3.77% | +0.29% | +6.72% | 8.54TCr | |
| Weighted average by Cap. | +0.04% | +3.04% | +2.38% | +3.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8L 10L 8L 7L 13.42L 9.11Cr 13.6L 90.95L 35.69L 4.55Cr 35.92L 35.14L 15Cr | 7L 8L 6L 6L 10.54L 7.16Cr 10.68L 71.42L 28.03L 3.58Cr 28.21L 27.6L 12Cr |
| Net income | -57.57L -66.34L -53.91L -49.31L -93.1L -63Cr -94.31L -6.31Cr -2.48Cr -32Cr -2.49Cr -2.44Cr -105.09Cr | -56.9L -65.57L -53.28L -48.74L -92.01L -62Cr -93.21L -6.23Cr -2.45Cr -31Cr -2.46Cr -2.41Cr -103.87Cr |
| Net Debt | 34.11L 39.3L 31.94L 29.21L 55.15L 37Cr 55.87L 3.74Cr 1.47Cr 19Cr 1.48Cr 1.44Cr 62Cr | 78.52L 90.48L 73.52L 67.26L 1.27Cr 86Cr 1.29Cr 8.6Cr 3.38Cr 43Cr 3.4Cr 3.32Cr 143.34Cr |
Employees
36
Calendar
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHE Stock
- TCLIF Stock
Select your edition
All financial news and data tailored to specific country editions
















